Accounts Payable, Accrued Expenses and Other

6 Months Ended

Jun. 30, 2018

5. Accounts Payable, Accrued Expenses and Other

Accounts payable, accrued expenses and other as of June 30, 2018 and December 31, 2017 consisted of the following:

(in thousands)	June 30, 2018		December 31, 2017
Accounts payable	$	1,750	$	2,887
Accrued goods and services		2,810		5,682
Accrued clinical trial costs		3,978		3,901
Accrued drug purchase costs		4,140		222
Accrued payroll and related benefits		1,489		2,884
Accrued restructuring expenses		—		628
Deferred tax incentives		1,402		1,402
Total accounts payable, accrued expenses and other	$	15,569	$	17,606